Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002044285-26-000005·Dauntless Investment Group, LLC
Schedule 13G ownership disclosure
OKYO PHARMA LTD
Common · CUSIP: G6724L116
Event date: 2025-12-31
- Filing-level shares
- 471,523.00
- Percent of class
- 1.2%
- Dauntless Investment Group, LLC
Shares: 471,523.00 · Class: 1.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002044285-26-000005
- Form type
- SCHEDULE 13G/A
- Filer
- Dauntless Investment Group, LLC
- CIK
- CIK 2044285
- Filed
- Feb 12, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership